Gyre Therapeutics (GYRE) Invested Capital (2010 - 2026)
Gyre Therapeutics (GYRE) reported Invested Capital of $137.0 million for Q1 2026, up 31.33% year-over-year from $104.3 million in Q1 2025, and up 29.19% on a QoQ basis from $106.0 million in Q4 2025.
Gyre Therapeutics (GYRE) has 17 years of Invested Capital data on file, last reported at $137.0 million in Q1 2026.
- Quarterly Invested Capital rose 31.33% year-over-year to $137.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $137.0 million (up 31.33% YoY) and the FY2025 annual result came in at $106.0 million, up 7.75% from the prior year.
- Invested Capital grew to $137.0 million in Q1 2026 per GYRE's latest filing, from $106.0 million in the prior quarter.
- Across five years, Invested Capital topped out at $137.0 million in Q1 2026 and bottomed at $13.9 million in Q4 2023.
- The 5-year median for Invested Capital is $88.8 million (2024), against an average of $83.5 million.
- The widest annual swing landed in 2023, when Invested Capital slumped 80.68%; it then soared 605.44% in 2024.
- Tracing GYRE's Invested Capital over 5 years: stood at $72.2 million in 2022, then tumbled by 80.68% to $13.9 million in 2023, then soared by 605.44% to $98.4 million in 2024, then climbed by 7.75% to $106.0 million in 2025, then gained by 29.19% to $137.0 million in 2026.
- Per Business Quant, the three latest GYRE Invested Capital figures stand at $137.0 million (Q1 2026), $106.0 million (Q4 2025), and $101.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | 136.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 136.99 Mn |
| Dec 31, 2025 | 106.03 Mn |
| Sep 30, 2025 | 101.92 Mn |
| Jun 30, 2025 | 129.44 Mn |
| Mar 31, 2025 | 104.30 Mn |
| Dec 31, 2024 | 98.40 Mn |
| Sep 30, 2024 | 98.47 Mn |
| Jun 30, 2024 | 93.35 Mn |
| Mar 31, 2024 | 88.77 Mn |
| Dec 31, 2023 | 13.95 Mn |
| Sep 30, 2023 | 85.32 Mn |
| Jun 30, 2023 | 77.47 Mn |
| Mar 31, 2023 | 77.33 Mn |
| Dec 31, 2022 | 72.22 Mn |
| Sep 30, 2022 | 29.38 Mn |
| Jun 30, 2022 | 79.06 Mn |
| Mar 31, 2022 | 27.08 Mn |
| Dec 31, 2021 | 59.47 Mn |
| Sep 30, 2021 | 60.74 Mn |
| Jun 30, 2021 | 85.16 Mn |
| Mar 31, 2021 | 104.09 Mn |
| Dec 31, 2020 | 76.07 Mn |
| Sep 30, 2020 | 94.06 Mn |
| Jun 30, 2020 | 108.96 Mn |
| Mar 31, 2020 | 97.52 Mn |
| Dec 31, 2019 | 68.34 Mn |
| Sep 30, 2019 | 81.27 Mn |
| Jun 30, 2019 | 93.11 Mn |
| Mar 31, 2019 | 105.82 Mn |
| Dec 31, 2018 | 119.95 Mn |
| Sep 30, 2018 | 129.95 Mn |
| Jun 30, 2018 | 136.96 Mn |
| Mar 31, 2018 | 142.85 Mn |
| Dec 31, 2017 | 30.77 Mn |
| Sep 30, 2017 | 24.88 Mn |
| Jun 30, 2017 | 30.35 Mn |
| Mar 31, 2017 | 13.84 Mn |
| Dec 31, 2016 | 16.07 Mn |
| Sep 30, 2016 | 19.63 Mn |
| Jun 30, 2016 | 23.61 Mn |
| Mar 31, 2016 | 28.19 Mn |
| Dec 31, 2015 | 32.58 Mn |
| Sep 30, 2015 | 36.88 Mn |
| Jun 30, 2015 | 99.53 Mn |
| Mar 31, 2015 | 103.23 Mn |
| Dec 31, 2014 | -109.35 Mn |
| Sep 30, 2014 | 113.39 Mn |
| Jun 30, 2014 | 117.72 Mn |
| Mar 31, 2014 | 124.88 Mn |
| Dec 31, 2013 | -102.16 Mn |
| Sep 30, 2013 | 147.61 Mn |
| Jun 30, 2013 | 159.05 Mn |
| Mar 31, 2013 | 170.31 Mn |
| Dec 31, 2012 | -92.49 Mn |
| Sep 30, 2012 | 191.41 Mn |
| Jun 30, 2012 | 197.23 Mn |
| Mar 31, 2012 | 179.60 Mn |
| Dec 31, 2011 | 175.53 Mn |
| Sep 30, 2011 | 183.61 Mn |
| Jun 30, 2011 | 191.01 Mn |
| Dec 31, 2010 | 93.56 Mn |